CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced
that it will present at the following investor conference in June:
Jefferies 2019 Healthcare Conference
New York, NY
Date: Tuesday, June 4, 2019
Speakers: August Troendle, President & Chief Executive
Officer, and Jesse Geiger, Chief Financial Officer & Chief Operating
Officer, Laboratory Operations
A live webcast of each presentation will be accessible through the
“Investors” section of the Company’s website at www.medpace.com
and will be available for replay following each event.
Medpace is a scientifically-driven, global, full-service clinical
contract research organization (CRO) providing Phase I-IV clinical
development services to the biotechnology, pharmaceutical, and medical
device industries. Medpace’s mission is to accelerate the global
development of safe and effective medical therapeutics through its
high-science and disciplined operating approach that leverages
regulatory and therapeutic expertise across all major areas including
oncology, cardiology, metabolic disease, endocrinology, central nervous
system, and anti-viral and anti-infective. Headquartered in Cincinnati,
Ohio, Medpace employs approximately 3,100 people across 36 countries.
Medpace Holdings, Inc.